Agenus Inc (NQ: AGEN )

5.375 USD +0.195 (+3.76%)

Streaming Delayed Price Updated: 3:59 PM EDT, Jun 23, 2021 Add to My Watchlist

Price and Volume

Volume	4,192,112
Open	5.180
Bid (Size)	5.370 (247)
Ask (Size)	5.380 (277)
Prev. Close	5.180
Today's Range	5.180 - 5.390
52wk Range	2.500 - 5.950
Shares Outstanding	222,441,009
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Agenus to Participate in the Raymond James 2021 Human Health Innovation Conference

June 21, 2021

Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer

June 17, 2021

Performance

YTD	+66.41%	+66.41%
1 Month	+33.37%	+33.37%
3 Month	+79.17%	+79.17%
6 Month	+56.71%	+56.71%
1 Year	+27.07%	+27.07%

More News

Agenus Announces Virtual Annual Shareholders Meeting

June 15, 2021

Agenus’ Presentations at ASCO 2021 Demonstrate Differentiated Activity of Balstilimab and Provide Clinical Update on AGEN2373

June 04, 2021

Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist

June 08, 2021

Agenus to Participate in Fireside Chat at the Jefferies 2021 Virtual Healthcare Conference

June 01, 2021

First Week of February 2022 Options Trading For Agenus (AGEN)

June 18, 2021

Noteworthy Thursday Option Activity: RGLD, COMM, AGEN

June 17, 2021

VBI Vaccines Granted FDA Fast Track Designation for VBI-1901 for the Treatment of Recurrent GBM

June 08, 2021

Hot Penny Stocks To Buy On Robinhood With Upcoming Events This Week

May 30, 2021

Agenus Gains As Balstilimab US Application Accepted For Review In Cervical Cancer

June 17, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.